Posted by Michael Wonder on 07 May 2020
How are incremental cost effectiveness, contextual considerations, and other benefits viewed in health technology assessment recommendations in the United States?
7 May 2020 - This study reviews ICER assessments to explore the relationship between incremental cost-effectiveness, other benefits, and contextual factors on the value vote.
Assessments published by the ICER between December 2014 and April 2019 were reviewed.
Thirty-one ICER assessments were reviewed, which included 51 value votes and 17 votes on other benefits and contextual considerations.
